Total Payments
$4,679
2024 Payments
$771.81
Companies
19
Transactions
152
Medicare Patients
7,494
Medicare Billing
$495,495
Payment Breakdown by Category
Food & Beverage$3,890 (83.1%)
Consulting$765.00 (16.3%)
Education$24.76 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,890 | 147 | 83.1% |
| Consulting Fee | $765.00 | 2 | 16.3% |
| Education | $24.76 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $877.05 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $604.91 | 34 | $0 (2024) |
| Novo Nordisk Inc | $535.87 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $421.05 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $372.92 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $316.69 | 14 | $0 (2023) |
| Baxter Healthcare | $315.00 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $230.63 | 15 | $0 (2023) |
| PFIZER INC. | $197.69 | 6 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $175.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $771.81 | 12 | Medtronic, Inc. ($532.50) |
| 2023 | $1,159 | 37 | Novo Nordisk Inc ($208.37) |
| 2022 | $936.26 | 16 | Baxter Healthcare ($315.00) |
| 2021 | $581.32 | 18 | Medtronic, Inc. ($263.51) |
| 2020 | $149.05 | 10 | E.R. Squibb & Sons, L.L.C. ($66.98) |
| 2019 | $504.58 | 27 | PFIZER INC. ($140.54) |
| 2018 | $296.90 | 13 | Janssen Scientific Affairs, LLC ($116.50) |
| 2017 | $280.40 | 19 | E.R. Squibb & Sons, L.L.C. ($105.84) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $35.62 | General |
| Category: Psychiatry/Psychology | ||||||
| 07/16/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 04/11/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 04/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology | ||||||
| 03/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiovascular | ||||||
| 03/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes | ||||||
| 02/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 01/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardiology | ||||||
| 12/29/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Heart Failure | ||||||
| 12/12/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $122.72 | General |
| 11/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: DIABETES | ||||||
| 11/22/2023 | Janssen Pharmaceuticals, Inc | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Cardiology | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 10/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: DIABETES | ||||||
| 10/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $81.04 | General |
| Category: Leads | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Cardiovascular | ||||||
| 08/18/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,660 | 2,056 | $373,424 | $104,065 |
| 2022 | 14 | 1,741 | 2,230 | $390,792 | $124,610 |
| 2021 | 17 | 1,960 | 2,540 | $421,150 | $143,585 |
| 2020 | 15 | 2,133 | 2,614 | $435,228 | $123,235 |
Total Patients
7,494
Total Services
9,440
Medicare Billing
$495,495
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 508 | 675 | $250,173 | $74,896 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 138 | 150 | $35,850 | $7,796 | 21.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 174 | 219 | $15,696 | $5,587 | 35.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 497 | 661 | $21,152 | $4,248 | 20.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 60 | 60 | $14,340 | $3,207 | 22.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $9,146 | $2,481 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $6,500 | $1,615 | 24.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 20 | 20 | $4,540 | $1,041 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,912 | $747.68 | 25.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 37 | 37 | $3,404 | $606.20 | 17.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 65 | 73 | $2,336 | $489.42 | 21.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 37 | 37 | $2,553 | $402.50 | 15.8% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Office | 2023 | 14 | 14 | $1,792 | $376.87 | 21.0% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 12 | 12 | $1,116 | $225.61 | 20.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 16 | 16 | $1,200 | $218.10 | 18.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 12 | 12 | $336.00 | $65.56 | 19.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 27 | 27 | $378.00 | $62.25 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 539 | 762 | $234,678 | $85,540 | 36.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 211 | 230 | $54,970 | $12,832 | 23.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $19,478 | $5,340 | 27.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 549 | 755 | $24,160 | $4,999 | 20.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 53 | 53 | $12,667 | $3,073 | 24.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 85 | 112 | $8,064 | $3,024 | 37.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $10,009 | $2,992 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 24 | $4,597 | $1,921 | 41.8% |
About Dr. Jonathan Gilbert, MD
Dr. Jonathan Gilbert, MD is a Interventional Cardiology healthcare provider based in Bannockburn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093735128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Gilbert, MD has received a total of $4,679 in payments from pharmaceutical and medical device companies, with $771.81 received in 2024. These payments were reported across 152 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,890).
As a Medicare-enrolled provider, Gilbert has provided services to 7,494 Medicare beneficiaries, totaling 9,440 services with total Medicare billing of $495,495. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Bannockburn, IL
- Active Since 07/20/2006
- Last Updated 10/06/2020
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1093735128
Products in Payments
- XARELTO (Drug) $403.20
- ELIQUIS (Drug) $378.17
- LINQ II (Device) $346.01
- Fluid Systems - Drug Delivery Systems (Device) $315.00
- Ozempic (Drug) $286.14
- ENTRESTO (Drug) $277.13
- JARDIANCE (Drug) $269.50
- CAMZYOS (Drug) $217.89
- BRILINTA (Drug) $199.06
- OPTIMIZER (Device) $175.94
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $161.65
- VYNDAQEL (Drug) $154.87
- LEQVIO (Drug) $143.92
- PRADAXA (Drug) $103.42
- Rybelsus (Drug) $102.06
- SELECTSECURE (Device) $81.04
- Repatha (Biological) $80.95
- Corlanor (Drug) $71.21
- Arcalyst (Drug) $45.41
- CARDIOMEMS (Device) $44.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.